The Diabetes Epidemic: Is Medication Masking the Problem?

USA Today

28-03-2025

The Diabetes Epidemic: Is Medication Masking the Problem?
In the United States, over 30 million people suffer from diabetes, while nearly 98 million are classified as pre-diabetic. Unfortunately, rather than addressing the fundamental lifestyle factors that contribute to Type 2 diabetes, patients and providers have become increasingly reliant on medications that slow the progression of the disease rather than reversing it.
The rise of GLP-1s, which were initially approved for diabetes management and later for obesity treatment, underscores this trend. While medications can provide short-term benefits, they often come with significant side effects, including muscle and bone mass loss, and in some cases, severe vision issues like ischemic optic neuropathy. These risks raise an important question: are these medications truly treating diabetes, or are they merely masking its symptoms while creating new health challenges?
Recent clinical research offers a compelling alternative to the medication-first approach. A groundbreaking study involving 100 Type 2 diabetes patients with BMIs over 27 and HbA1C levels above 6.5% compared the effectiveness of standard care versus an innovative intervention—the Fasting Mimicking Diet (FMD). This study, a randomized controlled trial, introduced the concept of "glycemic management," a metric that measures effectiveness based on medication reduction.
Participants in the FMD group underwent 12 monthly cycles of a 5-day fasting-mimicking regimen, conducted through L-Nutra Health, followed by 25 days of their regular diet, alongside standard diabetes care. The control group received standard diabetes care alone. The results were striking:
Medication Reduction: Participants in the FMD group were eight times more likely to reduce their medication dosage, with 56% either reducing or eliminating their medications entirely, compared to just 10% in the control group.
Glycemic Management: 53% of FMD participants showed more likelihood of lowering HbA1c or reducing diabetes medication use, compared to only 8% in the control group.
Improved Insulin Sensitivity: The FMD group demonstrated enhanced insulin sensitivity, allowing their bodies to better regulate blood sugar levels.
Anthropometric Benefits: Weight loss, reduced BMI, decreased waist circumference, and lower body fat percentages were observed, all without significant loss of fat-free mass (i.e., muscle).
'The results support our leadership within the 'Food is Medicine' movement by presenting a novel program that supports disease regression for most patients (needing fewer medications) and some with disease remission (needing no medication)' said Dr. William Hsu, Chief Medical Officer at L-Nutra Health and former VP of Harvard's Joslin Diabetes Center. 'This is the second successful FMD clinical trial in Type 2 diabetes, showing safety and enhanced efficacy over standard care alone.'
It's dangerous to become entrenched in a cycle of treating symptoms rather than underlying causes. The widespread use of medications—often prescribed in increasing doses over time—creates a dependency that not only fails to address root causes but also introduces new risks. Research suggests that around 10% of hospital admissions in people over 60 are due to medication-related issues, with polypharmacy (the use of multiple drugs simultaneously) exacerbating the problem. Meanwhile, nutritional and lifestyle-based solutions like FMD, which have been clinically proven to reduce or eliminate the need for diabetes medications, struggle to receive the same level of recognition or funding.
The evidence is clear—Type 2 diabetes does not have to be a life sentence of escalating medication use. Instead, interventions like FMD provide a viable alternative that can not only improve blood sugar levels but also reduce or eliminate the need for medication altogether.
Dr. Joseph Antoun, CEO of L-Nutra, passionately advocates for a shift in the current approach to diabetes management: 'Diabetes patients have been underserved with two impossible options: either to adhere to a strict daily dieting and lifestyle routine, or never-ending prescriptions of medications with chemicals and side effects. With the L-Nutra Health's Fasting Mimicking Diet programs, we have successfully enhanced the natural rejuvenating power of fasting with food, making the regression and remission of diabetes within every patient's reach.'
As long as medication-based treatments remain the standard of care, it is up to patients, healthcare providers, and policymakers to push for alternative solutions that address the root cause of disease rather than simply suppressing its symptoms. The future of diabetes care must be one that prioritizes sustainable, science-backed nutritional interventions—before it turns into an endless cycle of pharmaceutical dependency.
*This article is for informational purposes only and does not substitute for professional medical advice. If you are seeking medical advice, diagnosis or treatment, please consult a medical professional or healthcare provider.